SECTOR · UPDATED DAILY
Biotech Startups Recently Funded
125 Biotech companies on record, most common stage: Pre-Seed. $717K in total reported offering amounts. Sourced directly from SEC Form D filings, indexed within 24 hours of submission.
Recent filings
10 Most Recent Raises
| Company | Amount | Filing date | Stage | Location |
|---|---|---|---|---|
| Cynvec LLC | -- | -- | Seed | New York, NY |
| BioTraceIT Corp | -- | -- | -- | Philadelphia, PA |
| New Day Diagnostics LLC | -- | -- | -- | Knoxville, TN |
| Markman Biologics Corp | -- | -- | Pre-Seed | Las Vegas, NV |
| PERMEADERM, INC. | -- | -- | Pre-Seed | Carlsbad, CA |
| StemBioSys Inc. | -- | -- | Series A | San Antonio, TX |
| RHEONIX INC | -- | -- | Series B | Ithaca, NY |
| Efferent Labs, Inc. | -- | -- | Seed | Buffalo, NY |
| Monopar Therapeutics (MNPR) | -- | -- | Seed | Lake Forest, IL |
| Kellbenx Inc. | -- | -- | Series A | Great River, NY |
Stage breakdown
Companies by Stage
Bar width proportional to company count. Covers companies with stage classifications in the FlareSight database.
Data source
How We Source This Data
Every company on this page corresponds to a verified SEC Form D filing in the FlareSight database. Form D is a federal disclosure document issuers must file within 15 days of a first sale under Regulation D. It captures the issuer name, offering amount, and sector classification.
FlareSight pulls new filings from SEC EDGAR within 24 hours of submission and classifies each company by sector based on the filing and enrichment data. No press scraping, no estimates. Only primary-source SEC records.
Because Form D is a disclosure rather than an audited record, total offering amounts may include amounts not yet sold. Amendments to earlier filings can update the dollar figure. For the most current picture, browse the startup funding database.
Browse all Biotech companies
Filter by filing date, stage, location, and amount. See founder contacts and enrichment data. Free tier, no credit card.
Search Biotechcompanies →